Cite
Biochanin A, as the Lrg1/TGF-β/Smad2 pathway blockade, attenuates blood-brain barrier damage after cerebral ischemiare-perfusion by modulating leukocyte migration patterns.
MLA
Longsheng Fu, et al. “Biochanin A, as the Lrg1/TGF-β/Smad2 Pathway Blockade, Attenuates Blood-Brain Barrier Damage after Cerebral Ischemiare-Perfusion by Modulating Leukocyte Migration Patterns.” Biocell, vol. 47, no. 8, Aug. 2023, pp. 1869–83. EBSCOhost, https://doi.org/10.32604/biocell.2023.028602.
APA
Longsheng Fu, Jinfang Hu, Feng Shao, Yaoqi Wu, Wei Bai, Mingjin Jiang, Hao Chen, Lihua Chen, & Yanni Lv. (2023). Biochanin A, as the Lrg1/TGF-β/Smad2 pathway blockade, attenuates blood-brain barrier damage after cerebral ischemiare-perfusion by modulating leukocyte migration patterns. Biocell, 47(8), 1869–1883. https://doi.org/10.32604/biocell.2023.028602
Chicago
Longsheng Fu, Jinfang Hu, Feng Shao, Yaoqi Wu, Wei Bai, Mingjin Jiang, Hao Chen, Lihua Chen, and Yanni Lv. 2023. “Biochanin A, as the Lrg1/TGF-β/Smad2 Pathway Blockade, Attenuates Blood-Brain Barrier Damage after Cerebral Ischemiare-Perfusion by Modulating Leukocyte Migration Patterns.” Biocell 47 (8): 1869–83. doi:10.32604/biocell.2023.028602.